Zenas BioPharma, Inc. (ZBIO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Should you invest in Bicara Therapeutics Inc? Click for more on BCAX's promising cancer treatment, but proceed with caution ...

Positive 270-day Interim Clinical Study Data for the First Subject and Positive 180-day Interim Clinical Study Data for the Second Subject ...

水系电池由于具备本质安全、低成本、环保的特点，有望在未来大规模储能中实现应用，但是水系电池固有的瓶颈——负极界面的析氢问题严重限制了水系电池的寿命。电解质界面中间相（SEI）可以从动力学上抑制析氢反应，而传统的阴离子还原形成SEI高度依赖于高浓度的有 ...

INDIGO is the largest clinical trial conducted in patients living with IgG4-RD- -Topline INDIGO results expected by the end ...

IL-18 plays a key role in regulating innate immune responses, affecting natural killer cells, monocytes and other cell types.

Concluded targeted enrollment of Phase 3 INDIGO trial evaluating obexelimab for the treatment of Immunoglobulin G4-Related ...

Drs. Pankaj Mohan, CEO of Sonnet, and John Cini, CSO of Sonnet, discuss the Company’s recent issuance of a U.S. patent ...

The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development ...

HN01, a pivotal Phase 2/3 trial of ficerafusp alfa in 1L R/M HNSCC Completed upsized initial public offering, raising approximately $362 million in gross proceeds, with full ...

After 25 years of being one of the most beloved and reliable dual-sport motorcycles, Suzuki modernizes the 2025 DR-Z4S.